The company’s new approach, through a simple blood test, will ultimately accelerate the means of providing effective treatments to the right people at the right time.
For more than 15 years, the Focused Ultrasound Foundation has been dedicated to advancing the development and adoption of focused ultrasound.
Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder
Company plans to submit ONWARD results to both European and U.S. regulatory agencies.
AMPEL BioSolutions' Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
The technology is being utilized to launch a portfolio of 10+ clinical tests over the next five years to provide decision support for diseases affecting more than 50 million Americans.
UVA Health, Focused Ultrasound Foundation Partner to Create World’s First Focused Ultrasound Cancer Immunotherapy Center
$8 Million Investment to Fund Cutting-Edge Research, Launch Clinical Trials, Create Jobs
VIPC Regional Innovation Fund Grant Awarded to Charlottesville BioHub to Strengthen the Entrepreneurial Ecosystem in the Charlottesville Region
Funding will further Charlottesville BioHub’s goals to advance entrepreneurship in the area’s biotechnology sector and support tech and other innovation-led sectors with resourcing and connection.
The net proceeds of the offering strengthen Adial’s balance sheet as it moves toward completion of the Company’s Phase 3 ONWARD™ trial.
RIVANNA® expands world-class engineering team to advance development of the Accuro® Product Platform
As a domain expert in applications of diagnostic ultrasound imaging, Dr. Sheeran will lead projects primarily focused on Accuro XV CADe/x algorithm development and testing at RIVANNA.
Adial Pharmaceuticals Receives Notice of Allowance on the U.S. Patent for the Treatment for Opioid Use Disorder Using AD04
Patent covers patients with a specific genetic biomarker for the serotonin-3 receptor.
The developers of imaging-based medical solutions have received a contract from the Biomedical Advanced Research and Development Authority (BARDA) for the design and development of a computer-aided 3D fracture detection...